MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Mechanism-based classification in PD cohorts

B. Labrador, F. Danjou, S. Bekadar, FX. Lejeune, H. Froehlich, M. Hofmann-Apitius, JC. Corvol (Paris, France)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Mechanisms underlying therapeutic group singing in persons with Parkinson’s disease

E. Stegemoller, A. Zaman, K. Diaz, E. Shirtcliff, M. Kohut (Ames, IA, USA)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Medical management of primary hemifacial spasm

G. Kumar, D. Kaur, A. Singh (Patna, India)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Metabolomic Analysis of Fecal Matter from Parkinsonian Mice

V. Vedam-Mai, E. Gill, J. Koelmel, R. Yost, T. Garrett, M. Okun (Gainesville, FL, USA)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Methylation status of SNCA gene in patients with Parkinson disease in Russian population

E. Iakovenko, N. Abramycheva, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
MicroRNA Expression in the Diagnosis of Parkinson’s Disease

J. Roy, D. Guévremont, A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Mobility Impairments in Huntington’s Disease due to Cognitive Dysfunction

M. Rakhimova, N. Yusupova (Tashkent, Uzbekistan)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Modeling of Parkinson’s disease by damaging dopaminergic neurons

L. Toshpulatova, M. Kulmanova (Tashkent, Uzbekistan)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Modern aspects of genetics of child cerebral palsy with symptomatic epilepsy

D. Aminova (Tashkent, Uzbekistan)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Modulation of Na+/K+ ATPase activity of rat brain synaptosome by norepinepherine and serotonin

S. Sinha (Prayagraj, India)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley